CLIA-waived molecular influenza testing in the emergency department and outpatient settings.
CLIA-waived molecular influenza testing in the emergency department and outpatient settings.
复制标题
DOI：
10.1016/j.jcv.2019.05.002
复制
发表时间：
2019-07
期刊：
影响因子：
--
通讯作者：
Madej R
中科院分区：
文献类型：
--
作者：
Babady NE;Dunn JJ;Madej R
Respiratory tract infections are a common cause of visits to emergency departments and outpatient settings. Infections with influenza viruses A and B in particular, are responsible for significant morbidity and mortality in both pediatric and adult populations worldwide. A significant number of influenza diagnoses occur in the emergency departments with many being performed using rapid influenza diagnostic tests (RIDT) which have sensitivities as low as 30% depending on the specific RIDT and patient population. More recently, rapid molecular tests for the detection of influenza viruses A and B have become commercially available as point-of-care platforms. In the United States, several of these new tests are approved by the Food and Drug Administration as CLIA-waived tests. In this report, we review the data on the analytical and clinical performance of RIDTs and CLIA-waived molecular tests, present and discuss potential key challenges and opportunities for implementation of CLIA-waived molecular tests at or near point of care in the emergency departments and outpatient settings.
登录
查看更多内容
影响因子：
9.4
作者：
Ling, Lifen;Kaplan, Samuel E.;Tang, Yi-Wei
通讯作者：
Tang, Yi-Wei
影响因子：
3.7
作者：
Babady, N. Esther
通讯作者：
Babady, N. Esther
DOI：
10.1016/j.diagmicrobio.2018.07.002
发表时间：
2018-12-01
影响因子：
2.9
作者：
Hassan, Ferdaus;Crawford, Jordan;Selvarangan, Rangaraj
通讯作者：
Selvarangan, Rangaraj
影响因子：
4.4
作者：
Jennings LC;Skopnik H;Burckhardt I;Hribar I;Del Piero L;Deichmann KA
通讯作者：
Deichmann KA
DOI：
10.1186/s13054-014-0692-9
发表时间：
2014-12-08
期刊：
Critical care (London, England)
影响因子：
--
作者：
Rooney KD;Schilling UM
通讯作者：
Schilling UM